BIOLIFE SOLUTIONS INC | 0,286 Euro | -0,008 -2,72 % | |
| WKN: 894679 ISIN: US09062W1053 Ticker-Symbol: BJX | Berlin | 21.05.13 | 08:04 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 14.05. | BIOLIFE SOLUTIONS INC - 10-Q, Quaterly Report | - | SEC Filings | |
| 14.05. | BIOLIFE SOLUTIONS INC - 8-K, Current Report | - | SEC Filings | |
| 14.05. | BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of 2013 | 20 | PR Newswire | |
| BOTHELL, Wash., May 14, 2013 /PRNewswire/ --BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation... Mehr lesen zu: BioLife Solutions Announces Record Revenue of $2.2 Million in First Quarter of 2013 | ||||
| 07.05. | C O R R E C T I O N -- BioLife Solutions, Inc. | 60 | PR Newswire | |
| In the news release, BioLife Solutions Announces Participation and Additional Product Citations at 19th ISCT Annual Meeting, issued 06-May-2013 by BioLife Solutions, Inc. over PR Newswire, we are... Mehr lesen zu: C O R R E C T I O N -- BioLife Solutions, Inc. | ||||
| 06.05. | BioLife Solutions Announces Participation and Additional Product Citations at 19th ISCT Annual Meeting | 27 | PR Newswire | |
| BOTHELL, Wash., May 6, 2013 /PRNewswire/ --BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation... Mehr lesen zu: BioLife Solutions Announces Participation and Additional Product Citations at 19th ISCT Annual Meeting | ||||
| 02.05. | BioLife Solutions Announces License Agreement | 39 | PR Newswire | |
| BOTHELL, Wash., May 2, 2013 /PRNewswire/ --BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation... Mehr lesen zu: BioLife Solutions Announces License Agreement | ||||
| 11.04. | BioLife Solutions: Long-Term Potential Is Intact As Growth Continues | - | Seeking Alpha | |
| 04.02. | BioLife Solutions Appoints Rick Stewart To Board of Directors | 49 | PR Newswire | |
| BOTHELL, Wash., Feb. 4, 2013 /PRNewswire/ --BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and... Mehr lesen zu: BioLife Solutions Appoints Rick Stewart To Board of Directors | ||||
| 08.01. | DHI Global Medical Group Adopts BioLife Solutions' HypoThermosol as Improved Hair Graft Storage Medium | 20 | PR Newswire | |
| BOTHELL, Wash., Jan. 8, 2013 /PRNewswire/ --BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and... Mehr lesen zu: DHI Global Medical Group Adopts BioLife Solutions' HypoThermosol as Improved Hair Graft Storage Medium | ||||
| 07.01. | BioLife Solutions Reports Preliminary 2012 Revenue at $5.7 Million; Doubled from 2011 | 45 | PR Newswire | |
| BOTHELL, Wash., Jan. 7, 2013 /PRNewswire/ --BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and... Mehr lesen zu: BioLife Solutions Reports Preliminary 2012 Revenue at $5.7 Million; Doubled from 2011 | ||||
| 02.01. | BioLife Solutions To Present at OneMedForum 2013 | 61 | PR Newswire | |
| BOTHELL, Wash., Jan. 2, 2013 /PRNewswire/ --BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation... Mehr lesen zu: BioLife Solutions To Present at OneMedForum 2013 | ||||
| 12.12. | BioLife Solutions Announces TiGenix's Completion of Stem Cells and HypoThermosol Clinical Trial | 64 | PR Newswire | |
| BOTHELL, Wash., Dec. 12, 2012 /PRNewswire/ --BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation... Mehr lesen zu: BioLife Solutions Announces TiGenix's Completion of Stem Cells and HypoThermosol Clinical Trial | ||||
| 13.11. | BioLife Solutions Announces 2012 Third Quarter Results: Ninth Straight Quarter of Record Revenue | 19 | PR Newswire | |
| BOTHELL, Wash., Nov. 13, 2012 /PRNewswire/ --BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation... Mehr lesen zu: BioLife Solutions Announces 2012 Third Quarter Results: Ninth Straight Quarter of Record Revenue | ||||
| 29.10. | BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies | 35 | PR Newswire | |
| BOTHELL, Wash., Oct. 29, 2012 /PRNewswire/ --BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation... Mehr lesen zu: BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies | ||||
| 17.10. | BioLife Solutions Secures Exclusive Distribution Rights For Cellenergy' Hair Graft Storage Additive | 43 | PR Newswire | |
| BOTHELL, Wash., Oct. 17, 2012 /PRNewswire/ -- BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation... Mehr lesen zu: BioLife Solutions Secures Exclusive Distribution Rights For Cellenergy' Hair Graft Storage Additive | ||||
| 12.09. | BioLife Solutions Announces Presentation at IBC Inaugural Cell Therapy Clinical Development Conference | 21 | PR Newswire | |
| BOTHELL, Wash., Sept. 12, 2012 /PRNewswire/ --BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation... Mehr lesen zu: BioLife Solutions Announces Presentation at IBC Inaugural Cell Therapy Clinical Development Conference | ||||
| 14.08. | BioLife Solutions Announces 2012 Second Quarter Results: Eighth Straight Quarter of Record Revenue | 11 | PR Newswire | |
| BOTHELL, Wash., Aug. 14, 2012 /PRNewswire/ --BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation... Mehr lesen zu: BioLife Solutions Announces 2012 Second Quarter Results: Eighth Straight Quarter of Record Revenue | ||||
| 23.07. | BioLife Solutions Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite | 29 | PR Newswire | |
| BOTHELL, Wash., July 23, 2012 /PRNewswire/ -- BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation... Mehr lesen zu: BioLife Solutions Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite | ||||
| 09.07. | BioLife Solutions Completes First $1 Million Revenue Quarter | 24 | PR Newswire | |
| BOTHELL, Wash., July 9, 2012 /PRNewswire/ --BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation... Mehr lesen zu: BioLife Solutions Completes First $1 Million Revenue Quarter | ||||
| 01.06. | BioLife Solutions Restructures Term Debt; Secures 3-Year Extension on Maturity | 37 | PR Newswire | |
| BOTHELL, Wash., June 1, 2012 /PRNewswire/ --BioLife Solutions, Inc. (OTCBB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation... Mehr lesen zu: BioLife Solutions Restructures Term Debt; Secures 3-Year Extension on Maturity | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| BIOCRYST PHARMACEUTICALS | 1,289 | -0,39 % | FDA's New "Breakthrough" Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing / Five Star Equities Provides Stock Research on ACADIA Pharmaceuticals and BioCryst Pharmaceuticals |
| BIODELIVERY SCIENCES | 3,483 | -4,78 % | BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2013 Financials |
| BIOALLIANCE PHARMA | 4,289 | +0,94 % | BioAlliance Pharma : Disclosure of total number of voting rights and number of shares in the capital at April 30, 2013 |
| PEREGRINE PHARMACEUTICALS | 1,304 | -6,92 % | Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer / Phase III Registration Trial of Investigational Immunotherapy Expected to Start by Year-End |
| AMICUS THERAPEUTICS | 2,593 | -1,03 % | Amicus Therapeutics' CEO Presents at 2013 UBS Global Healthcare Conference (Transcript) |
